NDC properties for "adalimumab-adaz 40 MG per 0.4 ML Prefilled Syringe" (RxCUI 2641660)
About this data
The tables show NDC propoerties for adalimumab-adaz 40 MG per 0.4 ML Prefilled Syringe with the RxCUI 2641660
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for adalimumab-adaz 40 MG per 0.4 ML Prefilled Syringe (RxCUI 2641660)
| BLA | BLA761071 |
|---|---|
| MMSL_CODE | MTH_RXN_BD39595 |
| RxCUI | 2641660 |
| SPL_SET_ID | 3468792f-63ef-4916-8ed1-8214f327d9dd |
| VUID | 4042389 |
| Prescribable Synonym | adalimumab-adaz 40 MG in 0.4 ML Prefilled Syringe |
| RXNAV_STR | 0.4 ML adalimumab-adaz 100 MG/ML Prefilled Syringe |
| RxNorm Name | 0.4 ML adalimumab-adaz 100 MG/ML Prefilled Syringe |
| RxNorm Synonym | adalimumab-adaz 40 MG per 0.4 ML Prefilled Syringe |
| Related queries | Interactions (for RxCUI 2641660) |
NDC Properties
NDC Item 61314032764
| NDC 9 | 61314-327 |
|---|---|
| NDC 10 | 61314-327-64 |
| NDC Item | 61314032764 |
| Packaging | 2 SYRINGE, GLASS in 1 CARTON (61314-327-64) / .4 mL in 1 SYRINGE, GLASS |
| BLA | BLA761071 |
| FDA SPL set id | 866575 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 61314-327 |